Table 2 The monthly probability of developing CKD-related complications or conditions and the monthly change in GFR by CKD stage
From: The Chronic Kidney Disease Model: A General Purpose Model of Disease Progression and Treatment
Variable Description | CKD Stage 1 | CKD stage 2 | CKD stage 3 | CKD stage 4 | CKD stage 5 | Data Source |
|---|---|---|---|---|---|---|
Hypertension | 0.08% | 0.4% | 0.6% | 0.6% | 0.6% | |
Incidence of calcium/phosphorous abnormalities | 0.001% | 0.005% | 0.01% | 0.01% | 0.03% | [19] |
Bone disease (in those with calcium imbalance) | 0% | 80% | 90% | 100% | 100% | [19] |
Stroke | 0.003% | 0.003% | 0.003% | 0.006% | 0.006% | [24] |
MI (no pre-existing CVD) | 0.05% | 0.07% | 0.13% | 0.13% | 0.48% | [25] |
MI (with pre-existing CVD) | 0.27% | 0.31% | 0.50% | 0.50% | 1.00% | [25] |